Abbey Pain Scale for Dementia Patients
Assesses pain in patients with advanced dementia.
25 entries
Assesses pain in patients with advanced dementia.
Assesses number of lymphocytes and predicts CD4 count.
Frequently used to assess neutropenic fever in chemotherapy patients.
Predicts 10-year survival in patients with multiple comorbidities.
Stages dementia, including Alzheimer disease, in elderly patients.
Estimates mortality of community-acquired pneumonia to help determine inpatient vs. outpatient treatment.
Determines 1-year mortality in IPF patients using PFT and clinical indicators.
Determines ability of patient to tolerate therapies in serious illness, specifically for chemotherapy, simpler than the Karnofsky Scale .
Provides 1, 2, and 3-year mortality estimates for IPF patients.
Predicts survival to discharge with good outcome after in-hospital cardiac arrest.
Predicts overall and progression-free survival in DLBCL based on risk factors.
Diagnoses Alzheimer disease (AD), newer than NINCDS-ADRDA Criteria .
Determines ability of patient to tolerate chemotherapy.
Uses parent description of child’s activity to assess ability and response to treatment.
Predicts 2 year survival of small cell lung cancer.
Diagnoses Alzheimer disease (AD), alternative to IWG-2 Criteria .
Quantifies pain in patients unable to speak (due to intubation, dementia, etc).
Assesses pain in patients with dementia.
Predicts survival of CML based on clinical and lab information.
Predicts progression of clear cell renal cell carcinoma after radical nephrectomy.
Converts steroid dosages using dosing equivalencies.
No entries match your filter.